Study to Evaluate Switching From a Regimen Consisting of the Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (STR) to the Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate STR

Dupont Circle Physicians Group, P.C., Washington D.C.

Whitman Walker Clinic, Washington D.C.

Capital Medical Associates, PC, Washington D.C.

Infectious Disease Specialists of Atlanta, Decatur

Atlanta ID Group, Atlanta

Orlando Immunology Center, Orlando

The Kinder Medical Group, Miami

Be Well Medical Center, P.C., Berkley

Northstar Medical Center, Chicago

Southampton Healthcare, Inc., St Louis

Southwest Infectious Disease Clinical Research, Inc., Addison

Central Texas Clinical Research, Austin

Peter J. Ruane MD Inc, Los Angeles

Anthony Mills MD, Inc., Los Angeles

Living Hope Clinical Foundation, Long Beach

La Playa Medical Group and Clinical Research, San Diego

Peter Shalit, M.D., Seattle

Community Research Initiative of New England, Boston